Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-07-20
1992-12-29
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 514925, 514926, 514927, 514928, 514970, 514778, 514777, A61K 3736, A61K 3702
Patent
active
051751470
ABSTRACT:
This invention describes pharmaceutical compositions and methods of treating ulcerating diseases of the gastrointestinal tract in mammals with an acid-resistant fibroblast growth factor compositions. Also described is the use of acid-resistant fibroblast growth factor compositions in the treatment of various other fibroblast growth factor-responsive conditions.
REFERENCES:
patent: 4604234 (1986-08-01), Fujii
patent: 4689229 (1987-08-01), Banik
patent: 4745098 (1988-05-01), Michaeli
patent: 4816561 (1989-03-01), Todaro
Seno, Biochemical and Biophysical Research Communications, 151, No. 2, 701-708, 15 Mar. 1988.
P. A. Walicke, et al., Experimental Neurology, vol. 102, pp. 144-148 (1988).
K. A. Thomas, FASEB Journal, vol. 1, pp. 434-440 (1987).
R. R. Lobb, et al., Biochemistry, vol. 24, pp. 4969-4973 (1985).
Gospodarowicz et al., Endocrine Reviews, vol. 8, pp. 95-114 (1987).
Newswatch, Oct. 5, 1987, page 5.
G. M. Fox et al., The Journal of Biological Chemistry, vol. 263, pp. 18452-18458 (1988).
K. J. Anderson et al., Nature vol. 332, pp. 360-361 (1988).
R. S. Morrison et al., Proc. Natl. Acad. Sci. USA vol. 83, pp. 7537-7541 (1986).
Folkman Moses J.
Kato Koichi
Children's Medical Center Corporation
Conlin David G.
Moezie F. T.
Resnick David S.
Takeda Chemical Industries, Ltd
LandOfFree
Acid-resistant FGF composition and method of treating ulcerating does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acid-resistant FGF composition and method of treating ulcerating, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acid-resistant FGF composition and method of treating ulcerating will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1887123